Deficient natural killer cell (NK) activity and macrophage functioning in schizophrenic patients
Abstract
The cytotoxic potential of mononuclear blood cells from 27 chronic schizophrenic patients was evaluated using quantitative measures of natural killer cell activity and macrophage inhibition of tumor cell growth. 44% of the patients had some evidence of deficient in vitro mononuclear cell function which was not correlated with a qualitative or quantitative alteration in the histologic appearance of these peripheral blood cells.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Autistic patients showed no decrease in overall NK count, similar to schizophrenia, suggesting that the cells themselves are dysfunctional.
“Autistic patients showed no decrease in overall NK count, a similar result to schizophrenia (DeLisi et al, 1983), suggesting that it is the cells themselves that are dysfunctional.”
From The Role of the Immune System in Autism Spectrum Disorder (2017) · cites this paper as DeLisi et al, 1983
Cites
Natural Killer Cells: Their Roles in Defenses Against Disease
Herberman, R. B., & Ortaldo, J. R. (1981) · Science · doi:10.1126/science.7025208 · Cited by 1,343 · see citing works
Self-citationCharacteristics of human large granular lymphocytes and relationship to natural killer and K cells
Timonen, T. T., Ortaldo, J. R., & Herberman, R. B. (1981) · The Journal of Experimental Medicine · doi:10.1084/jem.153.3.569 · Cited by 991 · see citing works
Rorsman, B., Hagnell, O., Lanke, J., Baron, M., Levitt, M., Gruen, R. S., de Bonis, M., Baqué, E. F. I., Rinieris, P., Rabavilas, A. D., et al. (2008) · Neuropsychobiology · doi:10.1159/000117925 · Cited by 840 · see citing works
Low natural-killer-cell activity in familial melanoma patients and their relatives
Hersey, P., Edwards, A. M., Honeyman, M. C., & McCarthy, W. H. (1979) · British Journal of Cancer · doi:10.1038/bjc.1979.147 · Cited by 143 · see citing works
Schizophrenia and physical disease
Baldwin, J. A. (1979) · Psychological Medicine · doi:10.1017/s0033291700033948 · Cited by 133 · see citing works
VIGNES, H. (1948) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1948.tb96933.x · Cited by 128 · see citing works
Natural Killing in Immunodeficient Patients
Koren, H. S., Amos, D. B., & Buckley, R. H. (1978) · The Journal of Immunology · doi:10.4049/jimmunol.120.3.796 · Cited by 108 · see citing works
An analysis of lymphocyte subpopulations in schizophrenic patients.
Le, D., Goodman, S., Neckers, L. M., & Wyatt, R. J. (1982) · PubMed · Cited by 89 · see citing works
Self-citationMerrill, J. E., Jondal, M., Seeley, J., Ullberg, M., & Sidén, Å. (1982) · PubMed Central · Cited by 82 · see citing works
Abnormal Leukocytes in Schizophrenia
Fessel, W. J. (1963) · Archives of General Psychiatry · doi:10.1001/archpsyc.1963.01720180073010 · Cited by 73 · see citing works
Antinuclear antibodies in psychiatric illness: their relationship to diagnosis and drug treatment.
Johnstone, E. C., & Whaley, K. (1975) · BMJ · doi:10.1136/bmj.2.5973.724 · Cited by 72 · see citing works
Stimulated Lymphocytes in Schizophrenia
Hirata-Hibi, M. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290010058011 · Cited by 68 · see citing works
Aspects of humoral and cellular immunity in schizophrenia.
Vartanian, M. E., Kolyaskina, G. I., Dv, L., Burbaeva, G. S., & Ignatov, S. A. (1978) · PubMed · Cited by 64 · see citing works
Koren, H. S., & Williams, M. S. (1978) · The Journal of Immunology · doi:10.4049/jimmunol.121.5.1956 · Cited by 63 · see citing works
Natural Cell‐Mediated Cytotoxicity in Sjögren's Syndrome and Rheumatoid Arthritis
Goto, M., Tanimoto, K., Chihara, T., & Horiuchi, Y. (1981) · Arthritis & Rheumatism · doi:10.1002/art.1780241107 · Cited by 63 · see citing works
Immunoglobulins and Viral Antibodies in Psychiatric Patients
Torrey, Ε. F., Peterson, M. R., Brannon, W., Carpenter, W. T., Post, R. M., & van Kammen, D. P. (1978) · The British Journal of Psychiatry · doi:10.1192/bjp.132.4.342 · Cited by 62 · see citing works
Lymphocyte subpopulations in peripheral blood from schizophrenic patients
Yyland, H., NESS, A., & Lunde, H. (1980) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1980.tb00584.x · Cited by 60 · see citing works
Ortaldo, J. R., Bonnard, G. D., Kind, P. D., & Herberman, R. B. (1979) · The Journal of Immunology · doi:10.4049/jimmunol.122.4.1489 · Cited by 58 · see citing works
Self-citationQuantitative Determination of Immunoglobulins in CSF and Plasma of Chronic Schizophrenic Patients
DeLisi, L. E., Weinberger, D. R., Potkin, S. G., Neckers, L. Μ., Shiling, D. J., & Wyatt, R. J. (1981) · The British Journal of Psychiatry · doi:10.1192/bjp.139.6.513 · Cited by 52 · see citing works
Self-citationAbnormal immune regulation in schizophrenic patients.
Le, D., & Wyatt, R. J. (1982) · PubMed · Cited by 44 · see citing works
Self-citationTHE PAUCITY OF ARTHRITIS AMONG PSYCHOTIC CASES
Gregg, D. (1939) · American Journal of Psychiatry · doi:10.1176/ajp.95.4.853 · Cited by 42 · see citing works
Luchins, D. J., Torrey, E. F., Weinberger, D. R., Zalcman, S. J., DeLisi, L. E., Johnson, A., Rogentine, N., & Wyatt, R. J. (1980) · The British Journal of Psychiatry · doi:10.1192/bjp.136.3.243 · Cited by 39 · see citing works
Self-citationNeurochemical and immunologic components in schizophrenia
Borek, F. (1979) · Journal of Immunological Methods · doi:10.1016/0022-1759(79)90320-x · Cited by 36 · see citing works
Iványi, D., Zemek, P., & Ivanyi, P. (1976) · Tissue Antigens · doi:10.1111/j.1399-0039.1976.tb00571.x · Cited by 33 · see citing works
Blood Protein Fraction Comparisons of Normal and Schizophrenic Patients
Domino, E. F. (1975) · Archives of General Psychiatry · doi:10.1001/archpsyc.1975.01760240045003 · Cited by 31 · see citing works
Immunoglobulin levels in psychiatric patients
Strahilevitz, M., Fleischman, J. B., Fischer, G., Harris, R., & Narasimhachari, N. (1976) · American Journal of Psychiatry · doi:10.1176/ajp.133.7.772 · Cited by 30 · see citing works
Effects of psychoactive drugs on in vitro lymphocyte activation.
Rm, F., Schmidtke, J. R., & Rl, S. (1978) · PubMed · Cited by 30 · see citing works
Doust, J. W. L. (1952) · Journal of Epidemiology & Community Health · doi:10.1136/jech.6.1.49 · Cited by 24 · see citing works
KAMP, H. V. (1998) · PubMed · Cited by 23 · see citing works
The behavior of T lymphocytes in schizophrenia.
Liedeman, R. R., & Prilipko, L. L. (1978) · PubMed · Cited by 22 · see citing works
Antibody Response to Cholera Vaccine
Friedman, S. B. (1967) · Archives of General Psychiatry · doi:10.1001/archpsyc.1967.01730210052009 · Cited by 19 · see citing works
SCHIZOPHRENIA AND MALIGNANT NEOPLASMS IN A NORTH SWEDISH POPULATION
Modrzewska, K., & Böök, J. A. (1979) · The Lancet · doi:10.1016/s0140-6736(79)90806-7 · Cited by 16 · see citing works
Kaufman, D. B. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780250511 · Cited by 10 · see citing works
[Antinuclear antibodies and lupus due to phenothiazines in 600 hospitalized patients].
Ostaptzeff, G., Ostaptzeff, M., & Lavoine, J. R. (1975) · PubMed · Cited by 7 · see citing works
Flagged first, then by citations
1 of the 35 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
The Role of the Immune System in Autism Spectrum Disorder
Meltzer, A., & Van de Water, J. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.158 · Cited by 533 · see citing works
Reduced Natural Killer Cell Activity in Autism
WARREN, R. P., FOSTER, A., & MARGARETTEN, N. C. (1987) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-198705000-00008 · Cited by 190 · see citing works
Infection and Autoimmunity as Etiologic Factors in Schizophrenia: A Review and Reappraisal
Kirch, D. G. (1993) · Schizophrenia Bulletin · doi:10.1093/schbul/19.2.355 · Cited by 176 · see citing works
The behavior of APO-SUS rats in animal models with construct validity for schizophrenia
Ellenbroek, B. A., Geyer, M., & Cools, A. (1995) · Journal of Neuroscience · doi:10.1523/jneurosci.15-11-07604.1995 · Cited by 120 · see citing works
Cytokines production in chronic schizophrenia patients with or without paranoid behaviour
Cazzullo, C. L., Scarone, S., GRASSI, B., Vismara, C. S., Trabattoni, D., Clerici, M., & Clerici, M. (1998) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(98)00059-1 · Cited by 108 · see citing works
Immunological Dysfunction in Schizophrenia: A Systematic Approach
Rothermundt, M., Arolt, V., Weitzsch, C., Eckhoff, D., & Kirchner, H. (1998) · Neuropsychobiology · doi:10.1159/000026501 · Cited by 104 · see citing works
Family history of autoimmune diseases in psychosis
Gilvarry, C. M., Sham, P. C., Jones, P. B., Cannon, M. D., Wright, P., Lewis, S. W., Bebbington, P., Toone, B., & Murray, R. M. (1996) · Schizophrenia Research · doi:10.1016/0920-9964(95)00045-3 · Cited by 98 · see citing works
Increased Numbers of CD5 B Lymphocytes in Schizophrenic Patients
McAllister, C. G. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810100032006 · Cited by 95 · see citing works
Human psychoneuroimmunology today
Biondi, M., & Kotzalidis, G. D. (1990) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.1860040107 · Cited by 87 · see citing works
Sperner‐Unterweger, B., Whitworth, A. B., Kemmler, G., Hilbe, W., Thaler, J., Weiß, G., & Fleischhacker, W. W. (1999) · Schizophrenia Research · doi:10.1016/s0920-9964(98)00175-3 · Cited by 86 · see citing works
Cytokine production in drug-free and neuroleptic-treated schizophrenic patients
Bessler, H., Levental, Z., Karp, L., Modai, I., Djaldetti, M., & Weizman, A. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(94)00299-i · Cited by 86 · see citing works
Yovel, G., Sirota, P., Mazeh, D., Shakhar, G., Rosenne, E., & Ben‐Eliyahu, S. (2000) · Brain Behavior and Immunity · doi:10.1006/brbi.1999.0574 · Cited by 72 · see citing works
Increased interleukin-1 and interleukin-3 like activity in schizophrenic patients
Sirota, P. (1995) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(94)00106-r · Cited by 64 · see citing works
Is Schizophrenia a Viral or Immunologic Disorder?
DeLisi, L. E., & Crow, T. J. (1986) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(18)30638-5 · Cited by 64 · see citing works
Self-citationImmunity and schizophrenia: Autoimmunity, cytokines, and immune responses
Gaughran, F. (2002) · International review of neurobiology · doi:10.1016/s0074-7742(02)52013-4 · Cited by 56 · see citing works
Lymphocyte subsets in schizophrenic disorders
Masserini, C., Vita, A., Basile, R., Morselli, R., Boato, P., Peruzzi, C., Pugnetti, L., Ferrante, P., & Cazzullo, C. L. (1990) · Schizophrenia Research · doi:10.1016/0920-9964(90)90008-u · Cited by 56 · see citing works
Schizophrenia and Multiple Sclerosis
Stevens, J. R. (1988) · Schizophrenia Bulletin · doi:10.1093/schbul/14.2.231 · Cited by 56 · see citing works
Prestwood, T. R., Asgariroozbehani, R., Wu, S., Agarwal, S. M., Logan, R. W., Ballon, J. S., Hahn, M., & Freyberg, Z. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.113101 · Cited by 58 · see citing works
Changes of immunological functions after acute exacerbation in schizophrenia
Sasaki, T., Nanko, S., Fukuda, R., Kawate, T., Kunugi, H., & Kazamatsuri, H. (1994) · Biological Psychiatry · doi:10.1016/0006-3223(94)91149-5 · Cited by 52 · see citing works
Microglia dysfunction in schizophrenia: an integrative theory
Munn, N. A. (2000) · Medical Hypotheses · doi:10.1054/mehy.1999.0018 · Cited by 50 · see citing works
Reduced natural killer cell cytotoxicity in depression but not in schizophrenia
Caldwell, C. L., Irwin, M. R., & Lohr, J. B. (1991) · Biological Psychiatry · doi:10.1016/0006-3223(91)90183-m · Cited by 50 · see citing works
Gut permeability and its clinical relevance in schizophrenia
Ishida, I., Ogura, J., Aizawa, E., Ota, M., Hidese, S., Yomogida, Y., Matsuo, J., Yoshida, S., & Kunugi, H. (2022) · Neuropsychopharmacology Reports · doi:10.1002/npr2.12227 · Cited by 44 · see citing works
T-cell subsets in acute psychotic schizophrenic patients
Achiron, A., Noy, S., Pras, E., Lereya, J., Hermesh, H., & Laor, N. (1994) · Biological Psychiatry · doi:10.1016/0006-3223(94)91163-0 · Cited by 33 · see citing works
Immunological changes in the MPTP-induced Parkinson's disease mouse model
Bieganowska, K. D., Członkowska, A., Bidziński, A., Mierzewska, H., & Korlak, J. (1993) · Journal of Neuroimmunology · doi:10.1016/0165-5728(93)90209-h · Cited by 33 · see citing works
Antinuclear autoantibodies in chronic schizophrenia
Спивак, Б., Radwan, M., Bartur, P., Mester, R., & Weizman, A. (1995) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1995.tb09581.x · Cited by 30 · see citing works
Anticerebral antibodies in functional psychoses
Shima, S., Yano, K., Sugiura, M., & Tokunaga, Y. (1991) · Biological Psychiatry · doi:10.1016/0006-3223(91)90217-a · Cited by 29 · see citing works
Multiple Sclerosis and Schizophrenia
Arneth, B. M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081760 · Cited by 28 · see citing works
Mizruchin, A., Gold, I., Krasnov, I. B., Livshitz, G., Shahin, R., & Kook, A. I. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00144-7 · Cited by 28 · see citing works
Reduced splenic natural killer cell activity in rats with a hyperreactive dopaminergic system
Teunis, M., Heijnen, C. J., Cools, A. R., & Kavelaars, A. (2003) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2003.09.007 · Cited by 24 · see citing works
Shah, S. N., Johnson, R. C., Stone, R. K., & Mahon-Haft, H. (1985) · Biological Psychiatry · doi:10.1016/0006-3223(85)90134-9 · Cited by 24 · see citing works
Is schizophrenia linked to alteration in cellular immunity?
Sperner‐Unterweger, B., Barnas, C., Fleischhacker, W. W., Fuchs, D., Meise, U., Reibnegger, G. J., & WACHTER, H. (1989) · Schizophrenia Research · doi:10.1016/0920-9964(89)90035-2 · Cited by 21 · see citing works
O’Reilly, R. L. (1994) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/00048679409075632 · Cited by 20 · see citing works
TNFB polymorphism may be associated with schizophrenia in the Korean population
Jun, T., Pae, C., Chae, J., Bahk, W., Kim, K., Han, H. J., & Serretti, A. (2003) · Schizophrenia Research · doi:10.1016/s0920-9964(02)00303-1 · Cited by 18 · see citing works
Early effects of unilateral lesions of substantia nigra on immune reactivity
Deleplanque, B., Neveu, P. J., Vitiello, S., & Moal, M. L. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90437-c · Cited by 17 · see citing works
Current Perspectives on Immunology and Psychiatry
O׳Donnell, M., Silove, D. M., & Wakefield, D. (1988) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048678809161345 · Cited by 14 · see citing works
Genetic and Immunological Factors in Affective Disorders and Schizophrenia
Mendlewicz, J., & Sevy, S. M. (1986) · Progress in brain research · doi:10.1016/s0079-6123(08)60637-8 · Cited by 12 · see citing works
Nguyen, K. D., Amerio, A., Aguglia, A., Magnani, L., Parise, A., Conio, B., Serafini, G., Amore, M., & Costanza, A. (2023) · Cells · doi:10.3390/cells12162099 · Cited by 10 · see citing works
T-Lymphocyte Subsets and Schizophrenia
Kaufmann, C. A., DeLisi, L. E., Torrey, E. F., Folstein, S. E., & Smith, W. J. (1987) · Springer eBooks · doi:10.1007/978-1-4613-1799-9_28 · Cited by 10 · see citing works
Self-citationDopamine D1 Receptors in the Amygdala Enhance the Immune Response in the Rata
Nisticò, G., Caroleo, M. C., Arbitrio, M., & Pulvirenti, L. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb39674.x · Cited by 10 · see citing works
Cocaine induced T cell proliferation in the rat: role of amygdala dopamine D1 receptors
Caroleo, M. C., Arbirio, M., Francesco, P. D., Pulvirenti, L., Garaci, E., & Nistico, G. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00758-7 · Cited by 6 · see citing works
Increased Natural Killer Cells Activity in Schizophrenic Patients
Vodjgani, M., Matloubi, H., Nasehi, A. A., Nicknam, M. H., Kazemnejad, A., Salehi, E., Aboufazeli, T., & Gheflati, Z. (2005) · Cited by 5 · see citing works
Immunologic Studies of Schizophrenic Patients
DeLisi, L. E. (1987) · Springer eBooks · doi:10.1007/978-1-4613-1799-9_25 · Cited by 5 · see citing works
Self-citationStevens, J. R., & Hallick, L. M. (1992) · Infectious agents and pathogenesis · doi:10.1007/978-1-4684-5886-2_15 · Cited by 5 · see citing works
McDaniel, J. (1990) · Journal of Epidemiology & Community Health · doi:10.1136/jech.44.2.174-a · Cited by 3 · see citing works
Escelsior, A., Cilia, E., Favilla, L., Sterlini, B., Parisi, B., Guglielmo, R., Inuggi, A., da Silva, B. P., Filaci, G., Fenoglio, D., et al. (2025) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2025.2570169 · Cited by 2 · see citing works
Inadequate Provision for Electoconvulsive Therapy in the New South Wales Mental Health Act 1983
Durham, J. (1988) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048678809161349 · Cited by 2 · see citing works
Plasma protein variations in monozygotic twins discordant for schizophrenia
Putten, D. M. V., Torrey, E. F., Larive, A. B., & Merril, C. R. (1996) · Biological Psychiatry · doi:10.1016/0006-3223(95)00467-x · Cited by 2 · see citing works
Dopamine D1 Receptors in the Amygdala Enhance the Immune Response in the Rat
Nisticò, G., Caroleo, M. C., Arbitrio, M., & Pulvirenti, L. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb23115.x · Cited by 2 · see citing works
Dopaminergic Hyperactivity Accompanied by Hyperlocomotion in C57BL/6J-bgJ/bgJ (beige-J) Mice
Mori, T., Funada, M., Tsuda, Y., Maeda, J., Uchida, M., & Suzuki, T. (2014) · Journal of Pharmacological Sciences · doi:10.1254/jphs.14043sc · Cited by 1 · see citing works
Funada, M., Mori, T., Maeda, J., Tsuda, Y., Komiya, S., Shimizu, N., Kamei, J., & Suzuki, T. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.08.018 · Cited by 1 · see citing works
Lymphocyte Subsets in Schizophrenic Patients
Masserini, C., Ferrante, P., Vita, A., & Cazzullo, C. L. (1991) · Springer eBooks · doi:10.1007/978-1-4684-5811-4_13 · Cited by 1 · see citing works
Veränderungen von T-Lymphozyten Subsets bei schizophrenen Patienten
Barnas, C., Sperner‐Unterweger, B., Whitworth, A. B., Thaler, J., & Fleischhacker, W. W. (1993) · Springer eBooks · doi:10.1007/978-3-7091-9263-4_164 · Cited by 1 · see citing works
Maternal diet and atopic eczema.
Badrinath, P. (1990) · Journal of Epidemiology & Community Health · doi:10.1136/jech.44.2.174
Coffee, M. (2014) · SUNScholar (Stellenbosch University)
Verlaufsuntersuchung zellulärer Immunparameter bei schizophrenen Patienten
Möller, H. ‐. (2003)
Müller, N. (1995) · Monographien aus dem Gesamtgebiete der Psychiatrie · doi:10.1007/978-3-642-79842-9_7
- Authors
- DeLisi, L. E., Ortaldo, J. R., Maluish, A. E., & Wyatt, R. J.
- Affiliations
- National Institute of Mental Health (US)
- National Cancer Institute (US)
- St. Elizabeths Hospital (US)
- Venue
- Journal of Neural Transmission
- Published
- 1983-03
- Volume
- 58
- Issue
- 1-2
- Pages
- 99-106
- ISSN
- 0300-9564 (ISSN-L)
- 1435-1463
- OpenAlex
- W2009511885
- Cited by
- 56
- References
- 35
- Citations by year
- 2025: 1 · 2023: 1 · 2022: 1 · 2021: 1 · 2017: 1 · 2016: 1 · 2014: 3
- FWCI
- 1.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Neural Transmission (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
- Keywords
- schizophrenia, natural killer cells, macrophages, blood mononuclear cells, cytotoxicity, tumor cell growth inhibition, immunodeficiency, peripheral blood cells
- MeSH terms
- Adult, Chronic Disease, Cytotoxicity, Immunologic, Humans, Killer Cells, Natural, Macrophages, Middle Aged, Schizophrenia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
